Ropes & Gray Attorneys Examine New Rules Affecting the Pharmaceutical Industry in China
Shanghai-based life sciences counsel Katherine Wang and associate Fan Yang co-authored an article that examines the impact of recent transfer rule changes and new Good Manufacturing Practice requirements announced earlier this year by the China Food and Drug Administration. These developments present significant opportunities and considerations. The article, entitled “China Offers New Possibilities for Drug License Transfers,” published in the May/June 2013 issue of the Food and Drug Law Institute’s Update magazine.
Click here to view the full article. Reprinted with permission of FDLI.